in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Evotec Sells Drug Development Arm
11:07 AM MDT | September 18, 2007 | Alex Scott
Drug discovery firm Evotec (Hamburg, Germany) says it has sold its chemical development business to drug development services group Aptuit (Greenwich, CT) for $64 million in cash. Evotec’s chemical development business is comprised of activities in process research and development, custom preparation, analytical development, pilot plant manufacturing and formulation. The business has a total of about 210 people based in Oxford and Glasgow, U.K. and generated sales in 2006 of EUR €26.8 million ($37.2 million). "This acquisition continues Aptuit's...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee